FreeCME

GME Psychiatry Update

Jointly provided by Postgraduate Institute for Medicine and Global Medical Education.

Supported by an independent educational grant from Forest, Jazz, Lundbeck, Merck, Sunovion, and Takeda pharmaceuticals.

Release date: June 30, 2015

Valid through: June 30, 2016

Speciality: Psychiatry

Target Audience:

This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, and registered nurses involved in the care of patients with psychiatric illnesses.

This program consists of 6 continuing education activites.

Click the links below to review the activity launch pages containing full disclosure information.

Managing Depression and Mixed Episodes of Bipolar Disorder in the Real World

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify the red flags for bipolar disorder including the mixed specifier and DSM-5 changes in diagnosis.
  • Describe the evidence base for the treatment of patients with bipolar depression, mixed episodes and cognitive disturbances in major depression.
  • Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics
  • Formulate appropriate treatment regimens considering the emergence of new investigative agents
  • Provide appropriate care and counsel for patients and their families.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credits
  • Nurses — 0.9 contact hours
  • Nurse Practitioners1.0 contact hours
    Designated for 0.5 contact hours of pharmacotherapy credit.

All other healthcare professionals completing this course will be issued a statement of participation.

Start Managing Depression and Mixed Episodes of Bipolar Disorder in the Real World

 

Managing Sleep Disturbances in Psychiatric Patients

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Discuss the diagnosis and management of sleep disorders in psychiatric patients.
  • Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics.
  • Formulate appropriate treatment regimens considering the emergence of new investigative agents.
  • Provide appropriate care and counsel for patients and their families.

Credit Available

  • Physicians — maximum of 1.25 AMA PRA Category 1 Credits
  • Nurses — 1.2 contact hours
  • Nurse Practitioners — 1.0 contact hours
    Designated for 0.36 contact hours of pharmacotherapy credit for APRNs.

All other healthcare professionals completing this course will be issued a statement of participation.

Start Managing Sleep Disturbances in Psychiatric Patients

 

Recent Advances in the Treatment of Depression

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the evidence base for the treatment of patients with bipolar depression, mixed episodes, and major depression, including cognitive disturbances.
  • Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics
  • Formulate appropriate treatment regimens considering the emergence of new investigative agents
  • Provide appropriate care and counsel for patients and their families.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credits
  • Nurses — 1.0 contact hours
  • Nurse Practitioners — 1.0 contact hours
    Designated for 0.61 contact hours of pharmacotherapy credit for APRNs.

All other healthcare professionals completing this course will be issued a statement of participation.

Start Recent Advances in the Treatment of Depression

 

Recent Advances in the Treatment of Schizophrenia

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics
  • Formulate appropriate treatment regimens considering the emergence of new investigative agents
  • Provide appropriate care and counsel for patients and their families.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credits
  • Nurses — 0.8 contact hours
  • Nurse Practitioners — 1.0 contact hours
    Designated for 0.36 contact hours of pharmacotherapy credit for APRNs.

All other healthcare professionals completing this course will be issued a statement of participation.

Start Practical Strategies for Managing Side Effects of Psychiatric Medications

 

Towards a Better Understanding of Cognitive Disturbances in Depressed Psychiatric Patients

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the evidence base for the treatment of patients with bipolar depression, mixed episodes, and major depression, including cognitive disturbances.
  • Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics
  • Formulate appropriate treatment regimens considering the emergence of new investigative agents
  • Provide appropriate care and counsel for patients and their families.

Credit Available

  • Physicians — maximum of 0.75 AMA PRA Category 1 Credits
  • Nurses — 0.6 contact hours
  • Nurse Practitioners — 1.0 contact hours
    Designated for 0.31 contact hours of pharmacotherapy credit.

All other healthcare professionals completing this course will be issued a statement of participation.

Start Towards a Better Understanding of Cognitive Disturbances in Depressed Psychiatric Patients

 

Practical Strategies for Managing Side Effects of Psychiatric Medications

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the evidence base for the treatment of patients with bipolar depression, mixed episodes, and major depression, including cognitive disturbances.
  • Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics.
  • Formulate appropriate treatment regimens considering the emergence of new investigative agents.
  • Provide appropriate care and counsel for patients and their families.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credits
  • Nurses — 0.9 contact hours
  • Nurse Practitioners — 1.0 contact hours
    Designated for 1.0 contact hours of pharmacotherapy credit for APRNs.

All other healthcare professionals completing this course will be issued a statement of participation.

Start Practical Strategies for Managing Side Effects of Psychiatric Medications